All treatments
Treatment
Placebo for risankizumab clinical trials
2 indexed studies · 0 currently recruiting
- Active not recruitingPHASE3
A Study to Assess Adverse Events and Change in Disease Activity of Risankizumab Subcutaneous Induction Treatment for Moderately to Severely Active Crohn's Disease.
This study is looking at a new way to give risankizumab, a medicine for Crohn's disease, as an injection under the skin. It aims to see how well it works and if it's safe for adults with moderate to severe Crohn's disease.
For: Crohn's DiseaseUnited States · Argentina · Brazil - Active not recruitingPHASE3
A Study to Assess the Efficacy and Safety of Risankizumab in Participants With Ulcerative Colitis
This study looks at how well a medicine called risankizumab works and how safe it is for people with ulcerative colitis. It's for those who have already shown improvement with this medicine in a previous study.
For: Ulcerative Colitis (UC)United States · Argentina · Austria